Unnoticed Maternal Graves' Disease Revealed by the Baby's Low Free Thyroxine in Newborn Screening: an Underestimated Condition Supporting Thyroid Disease Screening Among Pregnant Women
Overview
Overview
Journal
J Endocrinol Invest
Publisher
Springer
Specialty
Endocrinology
Date
2017 Nov 3
PMID
29094333
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Kempers M, van Tijn D, van Trotsenburg A, de Vijlder J, Wiedijk B, Vulsma T
. Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. J Clin Endocrinol Metab. 2003; 88(12):5851-7.
DOI: 10.1210/jc.2003-030665.
View
2.
Slyper A, Shaker J
. Neonatal hypothyroxinemia with normal thyrotropin. Clue to maternal Graves' disease. Clin Pediatr (Phila). 1993; 32(2):121-3.
View
3.
Dosiou C, Barnes J, Schwartz A, Negro R, Crapo L, Stagnaro-Green A
. Cost-effectiveness of universal and risk-based screening for autoimmune thyroid disease in pregnant women. J Clin Endocrinol Metab. 2012; 97(5):1536-46.
DOI: 10.1210/jc.2011-2884.
View
4.
Andersen S, Olsen J, Carle A, Laurberg P
. Hyperthyroidism incidence fluctuates widely in and around pregnancy and is at variance with some other autoimmune diseases: a Danish population-based study. J Clin Endocrinol Metab. 2014; 100(3):1164-71.
DOI: 10.1210/jc.2014-3588.
View
5.
Soneda A, Adachi M, Muroya K, Asakura Y, Yamagami Y, Hirahara F
. Overall usefulness of newborn screening for congenital hypothyroidism by using free thyroxine measurement. Endocr J. 2014; 61(10):1025-30.
DOI: 10.1507/endocrj.ej14-0143.
View